BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TESS
3976
DELISTED
Tessco Technologies Inc
TESS
| $2.88M | ﹤0.01% |
468,768
-18,396
| -4% | -$135K |
|
3977
Vanguard Long-Term Treasury ETF
VGLT
$10B
| $2.87M | ﹤0.01% |
32,772
-40,151
| -55% | -$3.41M |
|
|
FARM
3978
DELISTED
Farmer Brothers
FARM
| $2.83M | ﹤0.01% |
223,112
-884,364
| -80% | -$9.65M |
|
|
CNCE
3979
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $2.83M | ﹤0.01% |
670,035
-1,657,183
| -71% | -$7.01M |
|
3980
TriplePoint Venture Growth BDC
TPVG
$184M
| $2.81M | ﹤0.01% |
185,325
+17,988
| +11% | +$277K |
|
3981
SELLAS Life Sciences
SLS
$1.97B
| $2.8M | ﹤0.01% |
252,480
+925
| +0.4% | +$9.03K |
|
3982
iShares MSCI Global Sustainable Development Goals ETF
SDG
$169M
| $2.8M | ﹤0.01% |
28,173
| – | – |
|
3983
FirstService
FSV
$6.48B
| $2.79M | ﹤0.01% |
16,271
-34
| -0.2% | -$5.58K |
|
|
PNNT
3984
Pennant Park Investment Corp
PNNT
$215M
| $2.78M | ﹤0.01% |
416,725
+42,460
| +11% | +$278K |
|
3985
Viper Energy
VNOM
$8.71B
| $2.78M | ﹤0.01% |
147,763
+42,330
| +40% | +$759K |
|
3986
PCB Bancorp
PCB
$392M
| $2.78M | ﹤0.01% |
172,833
-765,895
| -82% | -$12M |
|
|
YSG
3987
Yatsen Holding
YSG
$322M
| $2.78M | ﹤0.01% |
59,317
-9,432
| -14% | -$488K |
|
3988
PUT
PG&E
PCG
$38.3B
| $2.77M | ﹤0.01% |
+272,500
| New | +$2.92M |
|
3989
Loop Industries
LOOP
$35.3M
| $2.77M | ﹤0.01% |
224,500
-38,408
| -15% | -$374K |
|
3990
AC Immune
ACIU
$223M
| $2.76M | ﹤0.01% |
348,463
-276,654
| -44% | -$1.91M |
|
|
CTG
3991
DELISTED
Computer Task Group, Inc.
CTG
| $2.75M | ﹤0.01% |
284,706
-51,022
| -15% | -$512K |
|
3992
Janux Therapeutics
JANX
$925M
| $2.74M | ﹤0.01% |
+109,947
| New | +$2.45M |
|
3993
Cabaletta Bio
CABA
$437M
| $2.73M | ﹤0.01% |
317,188
-731,376
| -70% | -$7.19M |
|
3994
Arq
ARQ
$84.6M
| $2.72M | ﹤0.01% |
366,689
-913,938
| -71% | -$5.63M |
|
3995
Grupo Aval
AVAL
$6.27B
| $2.71M | ﹤0.01% |
475,937
-14,985
| -3% | -$89.2K |
|
|
OIG
3996
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
| $2.71M | ﹤0.01% |
15,509
+575
| +4% | +$100K |
|
|
OKUR
3997
OnKure Therapeutics
OKUR
$154M
| $2.7M | ﹤0.01% |
+28,982
| New | +$3.23M |
|
|
CMLS
3998
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $2.68M | ﹤0.01% |
182,670
+3,469
| +2% | +$36.7K |
|
|
FRMM
3999
Forum Markets
FRMM
$68.2M
| $2.66M | ﹤0.01% |
70
+2
| +3% | +$70.4K |
|
|
JWSM.U
4000
DELISTED
Jaws Mustang Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-fourth of one redeemable warrant
JWSM.U
| $2.62M | ﹤0.01% |
259,928
-1,128,395
| -81% | -$11.4M |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.